Healthcare provider profile · identity verified

Anesys Cabrera

Nurse Practitioner · MIAMI, FL · NPI 1598370926

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1037	368
Losartan Potassium	Losartan Potassium	535	167
Metformin Hcl	Metformin Hcl	468	132
Vitamin D2	Ergocalciferol (Vitamin D2)	360	131
Gabapentin	Gabapentin	351	116
Metoprolol Succinate	Metoprolol Succinate	330	109
Hydrochlorothiazide	Hydrochlorothiazide	329	112
Tamsulosin Hcl	Tamsulosin Hcl	302	95
Omeprazole	Omeprazole	293	109
Lisinopril	Lisinopril	288	93
Amlodipine Besylate	Amlodipine Besylate	285	96
Ammonium Lactate	Ammonium Lactate	284	87
Levothyroxine Sodium	Levothyroxine Sodium	279	80
Pantoprazole Sodium	Pantoprazole Sodium	231	78
Albuterol Sulfate Hfa	Albuterol Sulfate	229	52
Sildenafil Citrate	Sildenafil Citrate	216	38
Azithromycin	Azithromycin	213	150
Glimepiride	Glimepiride	203	51
Furosemide	Furosemide	198	55
Trazodone Hcl	Trazodone Hcl	197	75
Ibuprofen	Ibuprofen	196	108
Clopidogrel	Clopidogrel Bisulfate	171	51
Montelukast Sodium	Montelukast Sodium	163	48
Eliquis	Apixaban	161	30
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	150	74
Glipizide	Glipizide	145	42
Famotidine	Famotidine	142	54
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	142	22
Escitalopram Oxalate	Escitalopram Oxalate	139	59
Rosuvastatin Calcium	Rosuvastatin Calcium	138	80
Folic Acid	Folic Acid	133	48
Donepezil Hcl	Donepezil Hcl	131	47
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	130	37
Pioglitazone Hcl	Pioglitazone Hcl	127	34
Carvedilol	Carvedilol	124	36
Sertraline Hcl	Sertraline Hcl	122	51
Diclofenac Sodium	Diclofenac Sodium	118	69
Ketoconazole	Ketoconazole	105	77
Amoxicillin	Amoxicillin	102	80
Ciprofloxacin Hcl	Ciprofloxacin Hcl	98	79
Meclizine Hcl	Meclizine Hcl	98	53
Januvia	Sitagliptin Phosphate	93	16
Methocarbamol	Methocarbamol	92	66
Alprazolam	Alprazolam	90	22
Triamcinolone Acetonide	Triamcinolone Acetonide	90	64
Memantine Hcl	Memantine Hcl	89	40
Enalapril Maleate	Enalapril Maleate	87	29
Oxybutynin Chloride Er	Oxybutynin Chloride	87	28
Benzonatate	Benzonatate	84	58
Temazepam	Temazepam	84	25
Allopurinol	Allopurinol	82	24
Baclofen	Baclofen	77	47
Ofloxacin	Ofloxacin	76	63
Ciclopirox	Ciclopirox	74	40
Metoprolol Tartrate	Metoprolol Tartrate	74	28
Finasteride	Finasteride	70	23
Meloxicam	Meloxicam	70	44
Mirtazapine	Mirtazapine	69	28
Atenolol	Atenolol	68	19
Fluticasone Propionate	Fluticasone Propionate	67	26
Prednisone	Prednisone	66	40
Fenofibrate	Fenofibrate	65	27
Tadalafil	Tadalafil	65	18
Clonazepam	Clonazepam	63	22
Alendronate Sodium	Alendronate Sodium	61	20
Tramadol Hcl	Tramadol Hcl	61	20
Buspirone Hcl	Buspirone Hcl	60	27
Quetiapine Fumarate	Quetiapine Fumarate	60	24
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	57	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	56	18
Latanoprost	Latanoprost	55	18
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	52	suppressed
Simvastatin	Simvastatin	51	22
Brompheniramine-Pseudoephed-Dm	Brompheniramine/Pseudoephed/Dm	50	35
Spironolactone	Spironolactone	45	11
Chlorthalidone	Chlorthalidone	44	13
Cephalexin	Cephalexin	43	36
Glipizide Er	Glipizide	41	15
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	39	26
Cilostazol	Cilostazol	35	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	11
Citalopram Hbr	Citalopram Hydrobromide	34	12
Dicyclomine Hcl	Dicyclomine Hcl	34	suppressed
Duloxetine Hcl	Duloxetine Hcl	34	13
Nifedipine Er	Nifedipine	34	11
Propranolol Hcl	Propranolol Hcl	34	suppressed
Valsartan	Valsartan	34	suppressed
Irbesartan	Irbesartan	33	14
Bumetanide	Bumetanide	32	12
Hydralazine Hcl	Hydralazine Hcl	32	suppressed
Clonidine Hcl	Clonidine Hcl	31	18
Xarelto	Rivaroxaban	30	suppressed
Enulose	Lactulose	27	suppressed
Mupirocin	Mupirocin	27	23
Comfort Ez Pen Needle	Pen Needle, Diabetic	25	12
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	24	suppressed
Metronidazole	Metronidazole	24	18
Nystatin	Nystatin	24	23
Timolol Maleate	Timolol Maleate	24	suppressed
Alogliptin	Alogliptin Benzoate	23	suppressed
Lorazepam	Lorazepam	23	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	22	19
Ondansetron Hcl	Ondansetron Hcl	22	16
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Celecoxib	Celecoxib	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Entresto	Sacubitril/Valsartan	20	suppressed
Insulin Aspart Flexpen	Insulin Aspart	20	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	20	18
Clobetasol Propionate	Clobetasol Propionate	19	12
Potassium Chloride	Potassium Chloride	19	suppressed
Tradjenta	Linagliptin	19	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	18	14
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	18	suppressed
Metformin Hcl Er	Metformin Hcl	18	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	17	11
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Cefdinir	Cefdinir	16	15
Galantamine Hbr	Galantamine Hbr	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	15	suppressed
Ceftriaxone	Ceftriaxone Sodium	15	12
Isosorbide Dinitrate	Isosorbide Dinitrate	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Telmisartan	Telmisartan	15	suppressed
Embrace Pen Needle	Pen Needle, Diabetic	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Trifluoperazine Hcl	Trifluoperazine Hcl	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Jardiance	Empagliflozin	13	suppressed
Kenalog-80	Triamcinolone Acetonide	13	suppressed
Lactulose	Lactulose	13	suppressed
Pen Needle	Pen Needle, Diabetic	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	12	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Naproxen	Naproxen	11	11
Topiramate	Topiramate	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error